BCL2 and cancer: However, the inhibitory effect of monotherapy with cisPt and mAb as well as anti-MUC1 combined with PtPz4, PtPz6, and cisPt on Bcl-2 mRNA support rationality of applied therapy in anti-cancer treatment.